- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05034718
Implementation of the Pittsburgh Infant Brain Injury Score (PIBIS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Abusive head trauma is the leading cause of death due to physical abuse. Missing the diagnosis of abusive head trauma (AHT), particularly when it less severe is common and contributes to increased morbidity and mortality. Over the past 10 years, the investigators have derived and subsequently prospectively validated the Pittsburgh Infant Brain Injury Score (PIBIS), a point of care clinical decision rule to help physicians determine when it is appropriate to obtain neuroimaging in infants who present to the ED for evaluation of soft neurologic signs such as vomiting and fussiness. The results of the NIH multi-center prospective validation were published in 2016 in Pediatrics.
The next step in evaluating PIBIS as a clinical prediction rule is to perform an implementation study. Children less than 1 year of age presenting to the CHP ED for symptoms which place them at increased risk for AHT as defined in the PIBIS validation study will be potentially eligible.
Discrete fields in the electronic health record - including patient age, Emergency Severity Index (ESI), Glasgow Coma Scale (GCS) score, temperature and chief complaint - will be used to identify potentially eligible children in a systematic and efficient manner. Children who are potentially eligible based on this initial screen will trigger an alert to the nurse who will then complete a brief powerform to ensure eligibility and assess for inclusion/exclusion criteria. Due to the nature of the research, the investigators will seek a waiver of informed consent as has been done in similar studies at our institution and others. At this point, eligible children will be considered enrolled.
For children enrolled during the intervention period, providers will be presented with a detailed decision support strategy which encourages - but does not require - use of the PIBIS to make clinical decision re: the need for neuroimaging. For children enrolled during the control period, no other clinical decision support will occur. The duration of this evaluation period will be 24 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15224
- UPMC Children's Hospital of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 30 days to less than 1 year
- Chief complaint of Apnea, BRUE, Fussiness or Irritability, Lethargy, Neurologic complaint, Poor Feeding-Acute, Seizures/Spells, or Vomiting Alone
- First temperature in the ED less than or equal to 38.3C
- Acuity level/ESI of 3, 4, or 5
Exclusion Criteria:
- History of trauma related to this ED encounter
- Parent reported temperature of greater than 38.3C in the prior 24 hours
- Prior abnormal neuroimaging
- Previously enrolled in this study within preceding 28 days
- Provider preference for any reason
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Arm
Completion of nurse powerform and data collection only.
|
Standard of care, absent the PIBIS powerform and alert for providers.
|
|
Experimental: Intervention Arm
Completion of nurse powerform, data collection and physician alert/powerform with score calculation and recommendations.
|
The intervention is the presence of the PIBIS physician alert and powerform, which is clinical decision support for the treating provider if a patient meets inclusion criteria for Pittsburgh Infant Brain Injury Score (PIBIS) calculation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eligibility confirmation
Time Frame: From enrollment to hospital discharge, up to one month
|
Children identified as eligible by Cerner and confirmed by the nurse powerform as eligible for PIBIS will also be determined to be eligible after chart review and discussion with the clinician (which is how eligibility was determined during the validation study).
The primary outcome will be the concordance between these two methods of determining eligibility.
A concordance of >90% is the goal.
|
From enrollment to hospital discharge, up to one month
|
|
Proportion of children with PIBIS calculation and recommendations
Time Frame: From enrollment to hospital discharge, up to one month
|
The proportion of children eligible for PIBIS who
|
From enrollment to hospital discharge, up to one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of children who undergo neuroimaging (head CT or brain MRI) during the control and intervention periods
Time Frame: From enrollment to hospital discharge, up to one month
|
The proportion of children eligible for PIBIS who undergo neuroimaging (head CT or brain MRI) during the control and intervention periods
|
From enrollment to hospital discharge, up to one month
|
|
Proportion of neuroimaging which demonstrates an abnormality during the control and intervention periods
Time Frame: From enrollment to hospital discharge, up to one month
|
Proportion of neuroimaging which demonstrates an abnormality during the control and intervention periods
|
From enrollment to hospital discharge, up to one month
|
|
Proportion of all children with each PIBIS score who are ultimately diagnosed with physical abuse by the CHP Child Protection Team
Time Frame: From enrollment to hospital discharge, up to one month
|
Proportion of all children with each PIBIS score who are ultimately diagnosed with physical abuse by the CHP Child Protection Team
|
From enrollment to hospital discharge, up to one month
|
|
The number of enrolled children who return to the ED within 6 months of enrollment and undergo neuroimaging.
Time Frame: From enrollment to 6 months following hospital discharge
|
The number of enrolled children who return to the ED within 6 months of enrollment and undergo neuroimaging.
|
From enrollment to 6 months following hospital discharge
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rachel Berger, MD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY21010197
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Injury
-
Brent MaselThe Moody FoundationCompletedChronic Traumatic Brain InjuryUnited States
-
BrainScope Company, Inc.Active, not recruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
Center for Vision Development, New Market, MarylandUnknownBrain Injuries | Brain Injuries, Traumatic | Traumatic Brain Injury | Brain Injury, Chronic | Injury, Brain, TraumaticUnited States
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueRecruitingTBI (Traumatic Brain Injury)France
-
Queen Mary University of LondonCompleted
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Assiut UniversityUnknown
-
University of MiamiNeurolignCompletedBrain Injuries | Brain Injuries, Traumatic | Traumatic Brain Injury | Mild Traumatic Brain Injury | Head InjuryUnited States
Clinical Trials on Standard of care
-
brett rasmussenCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Emory UniversityNational Institute of Mental Health (NIMH)Active, not recruitingHiv | Sexual Behavior | Treatment Adherence | Adolescent Behavior | Reproductive Behavior | AIDS | Treatment ComplianceKenya
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Ruijin HospitalRecruitingCOVID-19 PneumoniaChina
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Ziv HospitalNot yet recruiting
-
Hofseth Biocare ASAKGK Science Inc.CompletedCovid-19 | COVIDCanada, Brazil, Hungary, Mexico, Serbia
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted